News

BioPharma Dive2d
Prasad’s FDA appointment pressures cell and gene therapy stocks
A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...
FDA picks critic of COVID boosters to be new top vaccines official
"You could replace Peter Marks with a bobblehead doll that just stamps approval and you would have the same outcome at FDA ...
pharmaphorum2d
Vinay Prasad will replace Marks as CBER director
Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...
BioSpace2d
Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER
The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...
The FDA names a new vaccine chief with an unsettling record, joining a controversial team
Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.
India Today on MSN2d
Indian-American doctor and anti-vaxxer picked to lead FDA's vaccines division
Indian-origin hematologist-oncologist, Vinay Prasad, a vocal critic of Covid-19 norms like mask policies and booster shots, ...